ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.

BACKGROUND/OBJECTIVE:Genetic polymorphisms in the inosine triphosphatase (ITPA) gene have been associated with the protection from early ribavirin(RBV)-induced hemolytic anemia among patients with chronic hepatitis C virus (HCV) infection. The aim of the present study was to investigate the associat...

Full description

Bibliographic Details
Main Authors:	Raoel Maan, Adriaan J van der Meer, Willem Pieter Brouwer, Elisabeth P C Plompen, Milan J Sonneveld, Robert Roomer, Annemiek A van der Eijk, Zwier M A Groothuismink, Bettina E Hansen, Bart J Veldt, Harry L A Janssen, Andre Boonstra, Robert J de Knegt
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4595504?pdf=render

Similar Items

Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease [version 1; referees: 3 approved]
by: Raoel Maan, et al.
Published: (2016-03-01)

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
by: Boris J. B. Beudeker, et al.
Published: (2022-10-01)

The ITPA disruption database
by: Eidietis, N.W., et al.
Published: (2018)

Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease
by: Nicole S Erler, et al.
Published: (2023-08-01)

Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy.
by: Mark A A Claassen, et al.
Published: (2012-01-01)

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients
by: Sylvia M. Brakenhoff, et al.
Published: (2023-02-01)

The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular Complications
by: Iulia Minciuna, et al.
Published: (2023-11-01)

Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving Telaprevir.
by: Alessio Aghemo, et al.
Published: (2014-01-01)

ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
by: Tarik Asselah, et al.
Published: (2015-01-01)

Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy
by: Sameen Amjed, et al.
Published: (2024-03-01)

Monocytes from chronic HBV patients react in vitro to HBsAg and TLR by producing cytokines irrespective of stage of disease.
by: Arjan Boltjes, et al.
Published: (2014-01-01)

Immune dissociation during acute hepatitis E infection
by: Jose D. Debes, et al.
Published: (2019-10-01)

Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV
by: Boris J.B. Beudeker, et al.
Published: (2024-02-01)

ITPA related developmental encephalopathy: Key role of neuroimaging
by: Dilek Çavusoglu, et al.
Published: (2022-01-01)

The rs1127354 Polymorphism in ITPA Is Associated with Susceptibility to Infertility
by: Fahimeh Mollaahmadi, et al.
Published: (2018-01-01)

Changing the odds: motives for and barriers to reducing HCV-related sexual risk behaviour among HIV-infected MSM previously infected with HCV
by: Femke Lambers, et al.
Published: (2018-12-01)

ITPA POLYMORPHISMS AND THE INCIDENCE OF TOXICITIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Patpetra Svasdisant, et al.
Published: (2023-02-01)

Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B
by: Warshan K. Katwaroe, et al.
Published: (2022-10-01)

B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis
by: Maaike Biewenga, et al.
Published: (2022-05-01)

Multi-Machine Global Confinement and H-mode Threshold Analysis ITPA Confinement and H-mode Threshold Database Working Group
by: Snipes, J.A.
Published: (2015)

Characterization of hepatitis C virus (HCV) envelope diversification from acute to chronic infection within a sexually transmitted HCV cluster by using single-molecule, real-time sequencing
by: Ho, C, et al.
Published: (2017)

High Prevalence of ITPA Alleles Associated with Ribavirin-Induced Hemolytic Anemia Among Mexican Population
by: Karina Gonzalez-Aldaco, et al.
Published: (2017-03-01)

Hepatitis E in Europe: Diagnosis and Treatment
by: Charlotte M. Nijskens, et al.
Published: (2015-12-01)

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
by: Laurens A. van Kleef, et al.
Published: (2021-10-01)

Positron emission tomography as a method for measuring drug delivery to tumors in vivo: the example of [11C]docetaxel
by: Astrid eVan Der Veldt, et al.
Published: (2013-08-01)

Hepatitis E Virus Shows More Genomic Alterations in Cell Culture than In Vivo
by: Gulce Sari, et al.
Published: (2019-11-01)

People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands.
by: Anouk T Urbanus, et al.
Published: (2011-01-01)

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
by: Frédégonde About, et al.
Published: (2015-01-01)

Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin
by: Osamu Yokosuka, et al.
Published: (2012-08-01)

ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease
by: A. Jena, et al.
Published: (2024-01-01)

Healthy and Happy Citizens: The Opportunities and Challenges of Co-Producing Citizens’ Health and Well-Being in Vulnerable Neighborhoods
by: Carola Van Eijk, et al.
Published: (2023-02-01)

Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis
by: Qiang Miao, et al.
Published: (2021-04-01)

Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapy.
by: Alenka Smid, et al.
Published: (2014-01-01)

Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism.
by: Hyery Kim, et al.
Published: (2012-01-01)

Evaluation of IL-28B polymorphisms and serum IP-10 in hepatitis C infected chimpanzees.
by: Babs E Verstrepen, et al.
Published: (2012-01-01)

Reply to: “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
by: Laurens A. vanKleef, et al.
Published: (2022-09-01)

Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients
by: Nashwa Eltantawy, et al.
Published: (2023-01-01)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
by: Borhan Moradveisi, et al.
Published: (2019-08-01)

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
by: Trevor J Morin, et al.
Published: (2012-01-01)

RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification
by: Ran Li, et al.
Published: (2023-03-01)